Covid Multiplex RT-PCR kit with extraction free technology - India CDSCO Medical Device Registration

Covid Multiplex RT-PCR kit with extraction free technology is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000028_2cd7a18ed67aa03d1d1415a516ea7ae0_924666d992ccc8a533e7049516ce8d2b. This device is marketed under the brand name RNAsure Pro. The license holder is Trivitron Healthcare Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

Covid Multiplex RT-PCR kit with extraction free technology

UID: MFG/IVD/2021/000028_2cd7a18ed67aa03d1d1415a516ea7ae0_924666d992ccc8a533e7049516ce8d2b

Brand Name

RNAsure Pro

License Holder

Trivitron Healthcare Pvt. Ltd.

Device Class

Class C

Approving Authority

CDSCO, Zonal office, Hyderabad

Product Information

The COVIDsure DIRECT is a multiplex RT-PCR Kit for rapid qualitative in vitro detection of SARS-CoV-2 (RNAsure Pro) directly from the VTM samples without RNA extraction from respiratory specimens (RNAsure Pro)

Class C

Brand: RNAsure Pro

Class C